Acute vascular rejection is associated with systemic complement activation ina pig-to-primate kidney xenograft model
- 1 August 2000
- journal article
- Published by Wiley in Xenotransplantation
- Vol. 7 (3), 186-196
- https://doi.org/10.1034/j.1399-3089.2000.00059.x
Abstract
The introduction of h‐DAF transgenic porcine organs into pre‐clinical pig‐to‐primate discordant xenotransplantation has led to complete and reliable abrogation of hyperacute xenograft rejection (HAR). Despite additional heavy immunosuppression however, most xenografts are still lost due to acute vascular rejection (AVR), with current treatment protocols being of only limited value. In a life‐supporting model of pig‐to‐primate kidney transplantation, unmodified (n = 8) or h‐DAF‐transgenic (n = 9) porcine kidneys were transplanted into cynomolgus monkeys under cyclophosphamide (CyP), cyclosporine and low‐dose steroid immunosuppression. Longest recipient survival was 11 days in the control group and 68 days in the h‐DAF transgenic group. Stable initial graft function with recipient survival > 4 days was generated in eight animals (two controls and six transgenics). In these animals, plasma complement levels were analyzed during ongoing AVR. Compared with baseline levels, a two‐fold increase in C3a levels and a four‐fold increase in sC5b‐9 levels were measured. In parallel to systemic complement activation, increased deposition of C3 and C5b‐9 along with massive staining for recipient IgM immunoglobulins was detected in the xenografts on immunohistochemistry. We conclude that acute vascular xenograft rejection of porcine kidneys in cynomolgus monkeys is associated with classical pathway complement activation following binding of induced recipient anti‐porcine antibodies. This complement activation can be observed despite membrane bound expression of human complement regulators in the porcine xenografts. Therefore, additional short‐term fluid phase complement inhibition seems necessary for the future development of protocols designed for treatment of AVR in the pig‐to‐primate combination.Keywords
This publication has 17 references indexed in Scilit:
- SUPPRESSION OF DELAYED XENOGRAFT REJECTION BY SPECIFIC DEPLETION OF ELICITED ANTIBODIES OF THE IgM ISOTYPE1Transplantation, 1999
- Acute vascular rejectionXenotransplantation, 1998
- Prolonged discordant xenograft survival and delayed xenograft rejection in a pig-to-baboon orthotopic cardiac xenograft modelThe Journal of Thoracic and Cardiovascular Surgery, 1998
- The role of antibodies in acute vascular rejection of pig-to-baboon cardiac transplants.JCI Insight, 1998
- PROTECTION OF PORCINE ENDOTHELIAL CELLS FROM COMPLEMENT-MEDIATED CYTOTOXICITY BY THE HUMAN COMPLEMENT REGULATORS CD59, C1 INHIBITOR, AND SOLUBLE COMPLEMENT RECEPTOR TYPE 1Transplantation, 1996
- INHIBITION OF COMPLEMENT, EVOKED ANTIBODY, AND CELLULAR RESPONSE PREVENTS REJECTION OF PIG-TO-PRIMATE CARDIAC XENOGRAFTS1Transplantation, 1996
- MOLECULAR BARRIERS TO XENOTRANSPLANTATION1Transplantation, 1996
- Prevention Of Complement-Mediated Activation Of Xenogeneic Endothelial Cells In An In Vitro Model Of Xenograft Hyperacute Rejection By C1 InhibitorTransplantation, 1993
- Cyclophosphamide ToxicityDrugs, 1991
- IMMUNOPATHOLOGY OF HYPERACUTE XENOGRAFT REJECTION IN A SWINE-TO-PRIMATE MODELTransplantation, 1991